Kestra Medical Technologies (KMTS) Change in Receivables (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Change in Receivables data on file, last reported at $2.9 million in Q2 2026.

• On a quarterly basis, Change in Receivables rose 202.49% year-over-year to $2.9 million in Q2 2026; TTM through Apr 2026 was $9.1 million, a 3.18% increase from a year earlier, with the FY2026 full-year figure at $9.1 million, up 3.18% from the prior year.
• Change in Receivables for Q2 2026 stood at $2.9 million, up from $2.7 million in the prior quarter.
• Over the last five years, Change in Receivables for KMTS reached as high as $3.3 million in Q1 2025 and fell as low as $963000.0 in Q2 2025.
• Historically, Change in Receivables has averaged $2.1 million across 3 years, with a median of $1.8 million in 2025.
• Across the five-year window, Change in Receivables plunged 38.51% in 2025 and surged 202.49% in 2026, its largest moves.
• Year by year, Change in Receivables stood at $1.6 million in 2024, then grew by 7.91% to $1.7 million in 2025, then soared by 70.85% to $2.9 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $2.9 million in Q2 2026, $2.7 million in Q1 2026, and $1.7 million in Q4 2025.